Why the study?
Does chronic atrial fibrillation augment muscle sympathetic nerve activity in heart failure patients compared to sinus rhythm?
Does chronic atrial fibrillation augment muscle sympathetic nerve activity in heart failure patients compared to sinus rhythm?
Chronic atrial fibrillation in heart failure patients is associated with augmented single-unit muscle sympathetic nerve activity, potentially contributing to disease progression.
Answers are grounded in this paper and cite their sources.
Should not yet change HF-AF management; leaves open whether AF augments sympathetic drive.
Atrial fibrillation (AF) is a common complication in heart failure (HF) patients. However, it remains unclear whether irregular ventricular response patterns induced by AF increase sympathetic nerve activity. We measured resting multi- and single-unit muscle sympathetic nerve activity (MSNA) in 21 age-matched HF patients with chronic AF (n = 11) rhythm or sinus rhythm (SR, n = 10). The multi-unit MSNA, which was expressed as total activity, was similar between HF + AF patients and HF + SR patients. However, the single-unit MSNA in HF + AF patients was significantly greater than that in HF + SR patients (62 ± 9 spikes min(-1) vs. 42 ± 4 spikes min(-1), P < 0.05). Moreover, the incidence of multiple firing of single-unit MSNA within a given burst was augmented in HF + AF patients as compared with HF + SR patients (48 ± 8% vs. 26 ± 3%, P < 0.01). A significant negative relationship was observed between the reduced diastolic pressure induced by a prolonged cardiac interval in AF subjects and single-unit MSNA frequency within one cardiac interval in each HF + AF subject. The firing characteristics of single-unit MSNA were different between HF patients with AF and HF patients with SR; particularly, those with a prolonged long RR interval showed multiple firings of single-unit MSNA. These findings suggest that AF per se leads to the instantaneous augmentation of single-unit MSNA induced by decreased diastolic pressure, which might partially contribute to disease progression in HF patients.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: